title: Authors' Reply.
authors.affiliation: Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.|TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts.
authors.forename: Grant W
authors.initials: GW
authors.lastname: Reed
authors.affiliation: TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts.
authors.forename: Jianping
authors.initials: J
authors.lastname: Guo
authors.affiliation: TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts.
authors.forename: Christopher P
authors.initials: CP
authors.lastname: Cannon
authors.affiliation: Department of Cardiovascular Medicine, Lahey Clinic, Burlington, Massachusetts.
authors.forename: Amit
authors.initials: A
authors.lastname: Kumar
authors.affiliation: Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.
authors.forename: Sary
authors.initials: S
authors.lastname: Aranki
authors.affiliation: Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.
authors.forename: Prem
authors.initials: P
authors.lastname: Shekar
authors.affiliation: Department of Surgery, St. Elizabeth's Medical Center, Brighton, Massachusetts.
authors.forename: Arvind
authors.initials: A
authors.lastname: Agnihotri
authors.affiliation: Division of Cardiology, St. James's Hospital, Dublin, Ireland.
authors.forename: Andrew O
authors.initials: AO
authors.lastname: Maree
authors.affiliation: Le Bauer Cardiology, Greensboro, North Carolina.
authors.forename: Dalton S
authors.initials: DS
authors.lastname: McLean
authors.affiliation: Department of Medicine, Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts.
authors.forename: Kenneth
authors.initials: K
authors.lastname: Rosenfield
mesh_terms: D001792:Blood Platelets / Q000187:drug effects*; D001026:Coronary Artery Bypass; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D010979:Platelet Function Tests / Q000379:methods*; D019095:Point-of-Care Systems; D058921:Purinergic P2Y Receptor Antagonists / Q000009:adverse effects*; D058925:Receptors, Purinergic P2Y12 / Q000187:drug effects*; D013988:Ticlopidine / Q000031:analogs & derivatives*
chemical_list: D010975:Platelet Aggregation Inhibitors; D058921:Purinergic P2Y Receptor Antagonists; D058925:Receptors, Purinergic P2Y12; D013988:Ticlopidine